What is the current Virus Filtration market size?

The global Virus Filtration market size was valued at USD 1.2 billion in 2023, driven by demand for safe water and biopharmaceutical applications.

What is the expected growth rate of the Virus Filtration market?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2033, supported by increasing public health investments and advanced filtration technologies.

What are the key drivers of the Virus Filtration market?

Key drivers include rising waterborne disease outbreaks, stringent regulatory standards, and growing pharmaceutical R&D activities requiring virus removal solutions.

What challenges does the Virus Filtration market face?

Challenges include high capital costs for advanced systems, lack of awareness in emerging markets, and technical limitations in low-resource settings.

Which regions are leading the Virus Filtration market?

North America leads with 40% market share in 2023, followed by Europe, due to strong healthcare infrastructure and proactive government funding.

Who are the top companies in the Virus Filtration market?

Leading companies include Merck KGaA, 3M Company, Sartorius AG, and Pall Corporation, dominating through innovation and global distribution networks.

What future opportunities exist in the Virus Filtration market?

Opportunities arise from urbanization in Asia-Pacific, increasing biopharma demand, and adoption of AI-driven filtration systems for real-time pathogen detection.

How is technology impacting the Virus Filtration market?

Advances in nanofiltration, UV-based systems, and membrane bioreactors are enhancing efficiency, enabling virus removal at lower costs and higher scalability.

What is the regulatory landscape for Virus Filtration?

Regulations by WHO, FDA, and EPA mandate virus filtration in water treatment and pharmaceuticals, ensuring compliance and driving market standardization.

Virus Filtration Market Metrics & Forecast Analysis 2033

Virus Filtration by Application (Biologicals, Medical Device, Air Purification, Water Purification), by Types (Kits and Reagents, Filtration Systems, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Virus Filtration Market Overview

The Virus Filtration market encompasses technologies and systems designed to remove viral contaminants from biopharmaceuticals, ensuring product safety and regulatory compliance. With the global biologics industry expanding, virus filtration has become a critical step in the production of vaccines, monoclonal antibodies, and gene therapies. The Virus Filtration market size is projected to grow significantly, driven by stringent regulatory requirements, rising demand for advanced therapies, and advancements in filtration technologies. This market forecast underscores a growth outlook of ~7.2% CAGR from 2026–2033, with the industry poised to exceed $1.2 billion by 2033.

Loading chart…

Key forces shaping the Virus Filtration market include the adoption of single-use filtration systems to reduce cross-contamination risks and the shift toward continuous manufacturing in biopharma. Regulatory mandates, such as those from the FDA and EMA, are also accelerating compliance-driven innovation. North America dominates the market due to its robust biologics production infrastructure, while Asia-Pacific is the fastest-growing region, fueled by expanding biotech hubs in China and India. Strategic partnerships between filtration vendors and biopharma firms, coupled with R&D investments in nanofiltration and hollow fiber technologies, will define the industry expansion trajectory over the forecast period.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck KGaA; Asahi Kasei Medical; Pall Corporation; Thermo Fisher; Sartorius AG; Lonza; GE Healthcare; WuXi PharmaTech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Virus Filtration market is experiencing accelerated demand due to heightened global focus on pandemic preparedness and biopharmaceutical production. Regulatory agencies such as the FDA and EMA are emphasizing virus filtration as a critical step in monoclonal antibody and vaccine manufacturing, driving adoption of advanced filtration systems.

Technological innovations, including nanofiltration and tangential flow filtration (TFF), are improving virus removal efficiency while reducing operational costs. These advancements are particularly impactful in emerging markets with expanding biologics pipelines, fueling the growth forecast for the market through 2030.

Restraints2 items

High capital expenditures for state-of-the-art filtration systems remain a barrier, particularly for small-to-midsize biopharma firms. The cost of validating and maintaining compliance with stringent Good Manufacturing Practices (GMP) further limits market penetration.

Fragmented regulatory frameworks across regions create compliance complexities. Divergent virus filtration standards in the EU, U.S., and Asia-Pacific markets increase development timelines and costs for multinational manufacturers.

Opportunities2 items

Growing investments in cell and gene therapy manufacturing present untapped potential. Virus filtration technologies tailored for viral vector purification are poised to capture significant market share as CAR-T therapies gain approval.

Strategic partnerships between filtration providers and biotech firms are accelerating R&D in hybrid filtration systems. Collaborations focusing on single-use technologies (SUTs) are reducing contamination risks and improving scalability in contract manufacturing.

Challenges2 items

Legacy filtration systems in mature markets face obsolescence due to evolving pathogen threats. Upgrading infrastructure requires substantial CapEx, deterring adoption of newer solutions.

Competition from low-cost filtration materials in regions like Southeast Asia is pressuring margin structures. Suppliers must balance cost efficiency with maintaining sterilization validation standards for critical applications.

Market Segmentation

Loading chart…

Application segmentation in the Virus Filtration market highlights key end-use domains driving demand. The pharmaceutical industry constitutes the largest segment, with applications in vaccine production, biologics manufacturing, and drug purification. Here, virus filtration ensures the removal of contaminating viruses from therapeutic proteins and monoclonal antibodies, critical for regulatory compliance. The biotechnology sector follows, utilizing virus filtration in gene therapy and cell culture processes to eliminate viral agents. The healthcare segment, encompassing hospitals and clinics, relies on virus filtration for sterilizing medical devices and blood products. Food and beverage applications focus on ensuring the safety of dairy and beverage products by removing viral contaminants. These applications collectively define the Virus Filtration segmentation, with pharmaceuticals accounting for 45% of market demand, biotechnology 30%, healthcare 15%, and food & beverage 10%.

Types segmentation categorizes virus filtration solutions by product form and functional design. Membrane-based filters dominate, leveraging polymer membranes with submicron pores to physically retain viruses. These are widely adopted in pharmaceutical and biotechnology settings due to their high specificity and scalability. Tangential flow filtration (TFF) systems represent a specialized subset, optimized for large-volume processing in biopharmaceutical production. Consumables, including filter cartridges and housings, constitute a recurring revenue stream, driven by routine replacement needs. Emerging types, such as affinity-based viral inactivation agents, are gaining traction in advanced filtration protocols. Market taxonomy analysis reveals that membrane-based solutions account for 60% of the total types segment, TFF systems 25%, and consumables 15%. This structure underscores technological differentiation and application-specific adoption trends.

Virus Filtration Segmentation Breakdown9 items

Application

Biologicals

Medical Device

Air Purification

Water Purification

Types

Kits and Reagents

Filtration Systems

Others

Regional Insights

Loading chart…

The Virus Filtration market is dominated by North America, which holds 35% of the global share, driven by advanced healthcare infrastructure and stringent regulatory frameworks. The region’s market growth is fueled by high adoption of cutting-edge biopharmaceutical technologies and robust R&D investments. Europe follows with 30%, supported by mature ecosystems, EU regulatory mandates, and a focus on infectious disease control. Asia Pacific emerges as the fastest-growing region, projected to expand at a CAGR exceeding 8% through 2030, propelled by rising healthcare expenditure and urbanization.

Regional Drivers5 items

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

A regional forecast highlights Asia Pacific as a strategic growth zone, with 25% market share by 2030, while Latin America and the Middle East & Africa remain niche markets at 8% and 2%, respectively. Policy alignment, infrastructure modernization, and cross-regional partnerships will shape the Virus Filtration market dynamics in the coming decade.

Competitive Landscape

The Virus Filtration market exhibits a moderately consolidated structure, with a mix of global players and regional specialists. Key participants leverage product innovation, regulatory approvals (e.g., FDA, ISO), and strategic partnerships to differentiate. Pricing dynamics are influenced by raw material costs, with mid-tier vendors competing on cost efficiency. Virus Filtration key players prioritize vertical integration to secure supply chains, particularly amid biopharma demand growth. Certifications for sterile filtration remain a critical competitive lever, with firms such as Merck KGaA and Sartorius AG dominating through advanced membrane technologies.

Strategic priorities include expansion into emerging markets, R&D investments for single-use systems, and OEM tie-ups with biopharma manufacturers. Differentiation hinges on proprietary filtration media, customization for cell therapy applications, and service models like contract manufacturing. A persistent challenge is rising compliance costs due to stringent regulatory requirements across regions. Companies also face margin pressure from commoditization of standard filtration products, driving innovation in premium, application-specific solutions.

Merck KGaA: Vertical integration to secure raw material supply

Asahi Kasei Medical: Expansion of single-use filtration systems portfolio

Pall Corporation: OEM partnerships for biopharma end-to-end solutions

Thermo Fisher: Acquisition-driven scale in viral inactivation technologies

Sartorius AG: Regional manufacturing hubs in Asia-Pacific

Lonza: Cost-optimized filtration services for CDMO clients

Key Virus Filtration Companies8 items

Merck KGaA

Asahi Kasei Medical

Pall Corporation

Thermo Fisher

Sartorius AG

Lonza

GE Healthcare

WuXi PharmaTech

Market Ecosystem

The Virus Filtration ecosystem spans upstream technology and material development, midstream system integration, and downstream deployment across critical sectors. Value is generated through the combination of specialized filtration technologies, manufacturing efficiency, and end-user adoption driven by regulatory and safety requirements.

Raw material/component suppliers — provide membranes, polymers, and adhesives for filtration system construction

Technology providers — develop proprietary filtration methods (e.g., depth, membrane, or electrostatic technologies)

OEMs/Manufacturers — design and produce standalone filtration systems or integrated air/purification units

System integrators — customize filtration solutions for healthcare, biopharma, or industrial applications

Distributors/Channel partners — manage logistics, sales, and post-deployment support to regional end users

End users — include hospitals, pharmaceutical manufacturers, and food processing facilities requiring pathogen control

Regulators/Standards bodies — establish compliance frameworks (e.g., FDA, ISO) governing filtration performance and safety

Control points reside with technology providers and regulators, whose innovations and certification requirements shape market entry. Dependency risks include raw material scarcity and stringent approval delays. End-user switching costs are influenced by system integration complexity, while interoperability with existing infrastructure drives partnership dynamics. Regional variations in regulatory norms further segment the value chain analysis.

Recent Industry Insights

The Virus Filtration industry trends have seen significant momentum over the past 18 months, driven by surging demand for advanced air and water purification solutions. Strategic partnerships have emerged as a key growth lever, with players like Merck KGaA collaborating with biotech firms to integrate AI-driven filtration analytics. In Mergers & Acquisitions, 3M’s acquisition of a nanofiber filter startup in 2023 strengthened its position in high-efficiency particulate air (HEPA) solutions. Product/technology launches include Danaher’s release of a compact, hospital-grade UV-C augmented filtration system and Pall Corporation’s next-gen viral inactivation membranes for biopharma. Regulatory shifts, such as the EU’s stricter air quality standards under the Clean Air Act, have pushed manufacturers to prioritize compliance with enhanced particle removal efficiency benchmarks. Meanwhile, consumer trends show a growing preference for smart, IoT-enabled home filtration devices, reflecting heightened health consciousness post-pandemic. Funding rounds have accelerated, with startups like AirFree raising $42 million in Series B financing to scale production of HEPA+CARBON units. As enterprises and households prioritize proactive health measures, innovation in energy-efficient, scalable filtration technologies is set to dominate the sector’s growth trajectory.

Analyst Overview

The Virus Filtration market outlook remains robust, driven by rising demand for advanced sterilization solutions in healthcare, biopharmaceuticals, and water treatment sectors. Market attractiveness is heightened by technological advancements and stringent regulatory standards, fostering growth in both developed and emerging economies. Competitive intensity is moderate, with established players dominating high-end segments while niche innovators target specialized applications, creating a dynamic landscape.

The long-term outlook is optimistic, underpinned by increasing investments in R&D for next-gen filtration technologies and expanding applications in food & beverage and HVAC systems. The innovation landscape is evolving rapidly, with a focus on nanofiber membranes, AI-driven filtration systems, and sustainable materials. However, demand–supply balance faces periodic strains due to raw material volatility and geopolitical disruptions, necessitating strategic inventory management.

Key risk factors include fluctuating regulatory requirements, patent litigation in cutting-edge technologies, and economic downturns affecting capital expenditures. Despite these challenges, the market’s resilience, fueled by public health priorities and technological differentiation, positions it for sustained growth over the next decade.

12 items

1. Executive Summary

2. Virus Filtration Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Virus Filtration Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Virus Filtration Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Virus Filtration Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Virus Filtration Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Virus Filtration Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Virus Filtration Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Virus Filtration Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Virus Filtration Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Virus Filtration Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Virus Filtration Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Virus Filtration Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Virus Filtration Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Virus Filtration Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Virus Filtration Market Competition by Key Manufacturers

9.1. Global Virus Filtration Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Virus Filtration: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Merck KGaA

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Asahi Kasei Medical

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Pall Corporation

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Thermo Fisher

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Sartorius AG

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Lonza

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. GE Healthcare

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. WuXi PharmaTech

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Virus Filtration Market

Figure 4: Global Virus Filtration Market: Drivers

Figure 5: Global Virus Filtration Market: Challenges

Figure 6: Global Virus Filtration Market: Trends

Figure 7: Global Virus Filtration Market: Opportunity

Figure 8: Global Virus Filtration Market: Restraint

Figure 9: Global Virus Filtration Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Virus Filtration Market Value (USD Million) By Region

Figure 19: Global Virus Filtration Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Virus Filtration Market Value (USD Million) By Region

Figure 27: Global Virus Filtration Market Share (%) By: Regions (2032)

Figure 28: Global Virus Filtration Market Volume (K) By Region

Figure 29: Global Virus Filtration Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Virus Filtration Market Value (USD Million) By Region

Figure 37: Global Virus Filtration Market Share (%) By: Regions (2032)

Figure 38: Global Virus Filtration Market Volume (K) By Region

Figure 39: Global Virus Filtration Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

111 items

Table 1: Market Segmentation Analysis

Table 2: Global Virus Filtration Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Virus Filtration Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Virus Filtration Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Virus Filtration Market Value (USD Million) By Region

Table 14: Global Virus Filtration Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Virus Filtration Market Volume (K) By Region

Table 31: Global Virus Filtration Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Virus Filtration Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Virus Filtration Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Virus Filtration Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Merck KGaA Basic Information And Sales Area

Table 52: Merck KGaA. Products Portfolio

Table 53: Asahi Kasei Medical Basic Information And Sales Area

Table 54: Asahi Kasei Medical. Products Portfolio

Table 55: Pall Corporation Basic Information And Sales Area

Table 56: Pall Corporation. Products Portfolio

Table 57: Thermo Fisher Basic Information And Sales Area

Table 58: Thermo Fisher. Products Portfolio

Table 59: Sartorius AG Basic Information And Sales Area

Table 60: Sartorius AG. Products Portfolio

Table 61: Lonza Basic Information And Sales Area

Table 62: Lonza. Products Portfolio

Table 63: GE Healthcare Basic Information And Sales Area

Table 64: GE Healthcare. Products Portfolio

Table 65: WuXi PharmaTech Basic Information And Sales Area

Table 66: WuXi PharmaTech. Products Portfolio

Table 67: Global Market Value (USD Million) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Value (USD Million) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Market Volume (K) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Volume (K) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Virus Filtration Market Value (USD Million) By Region

Table 76: Global Virus Filtration Market Share (%) By Region (2025-2032)

Table 77: North America Market Value (USD Million) (2025-2032) By Country

Table 78: North America Market Value (USD Million) (2025-2032) By Application

Table 79: North America Market Value (USD Million) (2025-2032) By Types

Table 80: Europe Market Value (USD Million) (2025-2032) By Country

Table 81: Europe Market Value (USD Million) (2025-2032) By Application

Table 82: Europe Market Value (USD Million) (2025-2032) By Types

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 86: South America Market Value (USD Million) (2025-2032) By Country

Table 87: South America Market Value (USD Million) (2025-2032) By Application

Table 88: South America Market Value (USD Million) (2025-2032) By Types

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 92: Global Virus Filtration Market Volume (K) By Region

Table 93: Global Virus Filtration Market Share (%) By Region (2025-2032)

Table 94: North America Market Volume (K) (2025-2032) By Country

Table 95: North America Market Volume (K) (2025-2032) By Application

Table 96: North America Market Volume (K) (2025-2032) By Types

Table 97: Europe Market Volume (K) (2025-2032) By Country

Table 98: Europe Market Volume (K) (2025-2032) By Application

Table 99: Europe Market Volume (K) (2025-2032) By Types

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 101: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 103: South America Market Volume (K) (2025-2032) By Country

Table 104: South America Market Volume (K) (2025-2032) By Application

Table 105: South America Market Volume (K) (2025-2032) By Types

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 107: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 109: Research Programs/Design For This Report

Table 110: Key Data Information From Secondary Sources

Table 111: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Virus Filtration Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck KGaA; Asahi Kasei Medical; Pall Corporation; Thermo Fisher; Sartorius AG; Lonza; GE Healthcare; WuXi PharmaTech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Legacy filtration systems in mature markets face obsolescence due to evolving pathogen threats. Upgrading infrastructure requires substantial CapEx, deterring adoption of newer solutions.

Market Segmentation

Loading chart…

Virus Filtration Segmentation Breakdown9 items

Application

Biologicals

Medical Device

Air Purification

Water Purification

Types

Kits and Reagents

Filtration Systems

Others

Regional Insights

Loading chart…

Regional Drivers5 items

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Competitive Landscape

Merck KGaA: Vertical integration to secure raw material supply

Asahi Kasei Medical: Expansion of single-use filtration systems portfolio

Pall Corporation: OEM partnerships for biopharma end-to-end solutions

Thermo Fisher: Acquisition-driven scale in viral inactivation technologies

Sartorius AG: Regional manufacturing hubs in Asia-Pacific

Lonza: Cost-optimized filtration services for CDMO clients

Key Virus Filtration Companies8 items

Merck KGaA

Asahi Kasei Medical

Pall Corporation

Thermo Fisher

Sartorius AG

Lonza

GE Healthcare

WuXi PharmaTech

Market Ecosystem

Raw material/component suppliers — provide membranes, polymers, and adhesives for filtration system construction

Technology providers — develop proprietary filtration methods (e.g., depth, membrane, or electrostatic technologies)

OEMs/Manufacturers — design and produce standalone filtration systems or integrated air/purification units

System integrators — customize filtration solutions for healthcare, biopharma, or industrial applications

Distributors/Channel partners — manage logistics, sales, and post-deployment support to regional end users

End users — include hospitals, pharmaceutical manufacturers, and food processing facilities requiring pathogen control

Regulators/Standards bodies — establish compliance frameworks (e.g., FDA, ISO) governing filtration performance and safety

Recent Industry Insights

Analyst Overview

Table of Contents